Skip to content

Atazanavir/ritonavir as potent over two years as Kaletra, but has better side-effects profile

Study finds evidence linking fat loss to the activity of the nervous system

Treatment started early in HIV infection effective and well tolerated for up to five years

CROI: More data on role of antiretrovirals, interventions, HCV, in cardiovascular disease risk

CROI: Studies begin to identify genes linked to metabolic and body fat changes

CROI: Lipodystrophy stable in children on HIV treatment and does not resolve after stopping d4T

CROI: Abacavir gene testing reveals high levels of hypersensitivity mutation

CROI: Disappointment for glitazones, metformin and testosterone for body fat changes

CROI: Capsaicin patch helps relieve neuropathy